PRICE T ROWE ASSOCIATES INC /MD/
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$490,538
+$448,104 QoQ
Shares Held
204,391
+121.6% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 148 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. LXRX ranks #208 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in LXRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $490,538 | 204,391 | Shares | Defined | 2026-08-14 | |
| 2025-03-31 | $42,434 | 92,248 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $57,351 | 77,502 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $183,971 | 117,179 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $196,860 | 117,179 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $252,756 | 105,315 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $154,057 | 100,691 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $109,753 | 100,691 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $248,203 | 108,386 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $380,589 | 156,621 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $370,755 | 194,113 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $463,860 | 193,275 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $367,240 | 197,441 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $321,717 | 153,932 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $565,910 | 143,632 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $623,222 | 129,568 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $594,717 | 129,568 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $604,204 | 102,931 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $615,856 | 180,075 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $485,820 | 337,375 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $674,750 | 337,375 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $445,526 | 228,475 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||